Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.
about
Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisCore Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic OpportunitiesHigh level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcomeCollaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia.How I treat paediatric relapsed acute myeloid leukaemia.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes.KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia.Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.The rocky road to personalized medicine in acute myeloid leukaemia.A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.CREB engages C/EBPδ to initiate leukemogenesis.Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
P2860
Q26771740-F409923E-07C0-4BD2-ABBB-10FC3984C6EEQ26863756-A3AA49ED-05EB-49D3-82D8-B870D23672C3Q33667247-BFBC7EC2-19DB-4AB0-B774-C22274C3D357Q36053792-B894C3CD-7496-44EA-A1AA-764C788F2860Q37648114-026D4866-7A3F-462D-88E7-0355BD4EB385Q37659087-80877CF6-A9E8-4431-BD3A-41B10FBBB526Q37687651-EE2DF965-D4EA-44C9-BD85-8A35A175BC4AQ38212509-4C6DA24E-6710-4F86-8296-29D775D225CBQ38263126-BC6C0F48-116E-4B51-A000-4773C2BC5219Q39883150-EDC12D14-7666-4252-906C-7BA7C59C8D7BQ40100589-F963B1FC-B3CD-4336-AEBC-EE49E047BDDEQ46370523-D8C7F750-796E-42ED-9AAB-EFBFD0914E68Q47561008-83F49D76-4FA9-4D04-99AA-31A999ACED41Q48268280-2D38AF9B-F0C0-4CFD-8028-E3D4FF10B250Q52671045-6FC89E40-0817-4926-BB14-969BE2497CC0Q55059131-79CED891-FD27-4BB7-95A8-60AD1B29F8F4
P2860
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@en
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@nl
type
label
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@en
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@nl
prefLabel
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@en
Core-binding factor acute myel ...... tic impact of c-KIT mutations.
@nl
P2093
P2860
P50
P356
P1433
P1476
Core-binding factor acute myel ...... stic impact of c-KIT mutations
@en
P2093
C Micalizzi
F Locatelli
R Rondelli
P2860
P2888
P304
P356
10.1038/LEU.2013.339
P577
2013-11-14T00:00:00Z